Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/01/21 | Don | Chief Technology Officer | 366,525 | 0.9431% | ||
| 26/01/21 | Don | Chairperson | 450,967 | 1.1604% | ||
| 26/01/21 | Tender | Director | 113,325 | 0.2916% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| -7.17% | -2.63% | +49.59% | +74.24% | 55.98B | |
| +0.24% | -5.62% | +54.73% | +125.15% | 53.69B | |
| +0.80% | -6.31% | +3.98% | +423.29% | 23.29B | |
| -0.09% | -0.01% | -17.62% | -14.67% | 23.15B | |
| -5.95% | -0.22% | +35.96% | -9.58% | 20.58B | |
| -1.14% | -3.16% | +32.88% | -28.80% | 17.76B | |
| -5.16% | -7.00% | +177.56% | +326.39% | 16.09B | |
| -6.91% | +2.40% | +36.86% | +636.97% | 15.93B | |
| +0.43% | -1.03% | +24.63% | +191.40% | 14B | |
| Average | -2.96% | -1.26% | +44.29% | +191.60% | 26.72B | |
| Weighted average by Cap. | -2.94% | -2.20% | +43.72% | +157.04% |
Employees
-
Choose MarketScreener 
